These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34863633)

  • 1. Evaluation of knowledge of the new Pregnancy and Lactation Labeling Rule among pharmacists and physicians.
    Alem G; Awuonda M; Haastrup D; Anyiwo A; Daftary M; Wingate L; Ettienne E
    J Am Pharm Assoc (2003); 2022; 62(2):427-431. PubMed ID: 34863633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicians' Perspective of the New Pregnancy and Lactation Labeling Rule (PLLR): Results from an AAAAI/FDA Survey.
    Namazy J; Chambers C; Sahin L; Johnson T; Dinatale M; Lappin B; Schatz M
    J Allergy Clin Immunol Pract; 2020 Jun; 8(6):1947-1952. PubMed ID: 32084595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of knowledge of the new pregnancy and lactation labeling rule among pharmacists and physicians in Saudi Arabia.
    Alem G; Ahmed N; Aldurayhim H; Almukhaizeem R; Almalki Z; Alshehri A; Alahmari A
    Medicine (Baltimore); 2024 Aug; 103(32):e38995. PubMed ID: 39121290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule.
    Byrne JJ; Saucedo AM; Spong CY
    JAMA Netw Open; 2020 Aug; 3(8):e2015094. PubMed ID: 32865574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Influence of the Food and Drug Administration Pregnancy and Lactation Labeling Rule on Drug Information Resources.
    Harris JB; Holmes AP; Eiland LS
    Ann Pharmacother; 2021 Apr; 55(4):459-465. PubMed ID: 32885981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the Pregnancy and Lactation Labeling Rule (PLLR) on Practicing Dermatologists.
    Beroukhim K; Abrouk M; Farahnik B
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization.
    Gruber MF
    Vaccine; 2015 Nov; 33(47):6499-500. PubMed ID: 26256527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
    Brucker MC; King TL
    J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacists' services for women during pregnancy and breast feeding in Kuwait: a cross-sectional study.
    Albassam A; Awad A
    BMJ Open; 2018 Jan; 8(1):e018980. PubMed ID: 29306891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Importance of Clinical Research in Pregnant Women to Inform Prescription Drug Labeling.
    Dinatale M; Roca C; Sahin L; Johnson T; Mulugeta LY; Fletcher EP; Yao L
    J Clin Pharmacol; 2020 Dec; 60 Suppl 2():S18-S25. PubMed ID: 33274508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacists' attitudes, barriers, knowledge and counseling practice with regard to preconception, pregnancy and lactation.
    Ceulemans M; Liekens S; Van Calsteren K; Allegaert K; Foulon V
    Res Social Adm Pharm; 2020 Sep; 16(9):1192-1200. PubMed ID: 31864884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge and practice characteristics of pharmacists in Qatar towards medication use in pregnancy: a cross-sectional survey.
    Rouf PA; Thomas B; Elkassem W; Tarannum A; Al Saad D; Gasim MM; Al Hail M
    East Mediterr Health J; 2018 May; 24(2):137-145. PubMed ID: 29748942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Texas pharmacists' knowledge of reporting serious adverse drug events to the Food and Drug Administration.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    J Am Pharm Assoc (2003); 2011; 51(3):397-403. PubMed ID: 21555292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare providers' use of a concise summary to prescribe for lactating patients.
    Koenig T; Robins C; Darby Lipman P; Dinatale M; Johnson T; Sahin L; Roca C; Limpert J; Baisden K; Mulugeta Y; Yao L; Jennings KA; Alimchandani M; Everett D; Gassman A; Chang C; Ellis C; Pfuma Fletcher E; Samuels S
    Res Social Adm Pharm; 2024 May; 20(5):531-538. PubMed ID: 38413289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of pharmacists' knowledge of women's issues in epilepsy.
    McAuley JW; Casey J; Long L
    Epilepsy Behav; 2009 Jan; 14(1):243-6. PubMed ID: 19000933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication use in pregnancy and the pregnancy and lactation labeling rule.
    Sahin L; Nallani SC; Tassinari MS
    Clin Pharmacol Ther; 2016 Jul; 100(1):23-5. PubMed ID: 27082701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacists' knowledge of and attitudes toward oral chemotherapy.
    O'Bryant CL; Crandell BC
    J Am Pharm Assoc (2003); 2008; 48(5):632-9. PubMed ID: 18826902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' knowledge of the safety of antibiotics for systemic use.
    Yakimova Y
    Int J Risk Saf Med; 2015; 27 Suppl 1():S11-2. PubMed ID: 26639686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Lactation Studies of Neuropsychiatric Medications: Clinical Pharmacology and Labeling Considerations.
    Nallani SC; Baisden K; Dinatale M; Basham L; Kwatra D; Yao L
    J Clin Pharmacol; 2023 Jun; 63 Suppl 1():S159-S169. PubMed ID: 37317496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of non-prescription medicines during lactation: A qualitative study of community pharmacists' attitudes and perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2018 May; 14(5):464-470. PubMed ID: 28624292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.